News

The UW Program for Advanced Cell Therapy (PACT) will conduct a study to examine a cutting-edge therapy to treat a viral infection faced by up to 50 percent of bone-marrow transplant recipients.

Every summer since 2007, students from some of the smallest high schools in Wisconsin have descended upon campus for the Morgridge Rural Summer Science Camp. The immersion program has allowed more than 500 high-academic achievers from across the state to spend a week learning from leaders in stem cell research. The students arrive passionate and motivated in science, but the hope is this deep dive into real research will seal the deal for a future scientific caree

Together with the University of Wisconsin-Madison, we look back on 20 years of stem cell research and see where we’re going next. Catch up on what’s happened since James Thomson’s prescient prediction that stem cells “will change medicine, period.”

Today we bring you the first in a series of four videos about stem cell research here at UW–Madison: how it started, what it’s achieved, and where it’s headed.

Fujifilm Cellular Dynamics Inc. (FCDI) plans to invest $21 million to create a facility in Madison for manufacturing stem cell therapies that can be used as regenerative medicine — cells that can repair or rebuild a patient’s diseased or damaged tissue.

Peiman Hematti, MD, a bone marrow transplant physician at the University of Wisconsin Carbone Cancer Center and director of Clinical Hematopoietic Cell Processing Laboratory, is the site principal investigator for a new clinical trial using …

As an undergraduate student majoring in physics at Illinois Wesleyan University, William Murphy took exactly one biology course: Biology 101. Two decades later, he’s built a career around creating what he calls “bio-inspired” materials such as tissues for drug modeling and bone regeneration. Murphy, the Harvey D. Spangler Professor of biomedical engineering and orthopedics at the University of Wisconsin-Madison, looks to nature for insights on his designs.

At just two-and-a-half years old, the University of Wisconsin–Madison Human Stem Cell Gene Editing Service is already contemplating expansion. The increased demand has tracked the growth of research projects on campus using a new gene …

An article in the Wisconsin State Journal described the first combined kidney and hematopoietic stem cell transplant at UW-Madison. Members of the multidisciplinary team that made the breakthrough possible included SCRMC member Peiman Hematti, MD, professor, Hematology, Medical Oncology and Palliative Care, as well as Kristi Schneider, APRN-BC, APNP, director of transplant clinical trials, Department of Surgery, Robert Redfield III, MD, assistant professor, Department of Surgery, and Kristin Bradley, MD, associate professor, Department of Human Oncology.

A series of projects aimed at advancing the human-health and economic impact of biomanufacturing is already benefiting from a new University of Wisconsin–Madison institute aimed at making the state a Midwestern hub of the ongoing merger of pharmaceuticals, medical devices and cutting-edge tissue engineering. The Forward BIO Institute, announced last month, intends to accelerate UW–Madison’s existing expertise in the next wave of biomedicine. Former SCRMC Co-Director, William Murphy, a professor of biomedical engineering and orthopedics at UW–Madison, directs the Institute.